Skip to main content
SpringerLink
Log in

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

  • Aso Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dasari A, Shen C, Halperin D, Zhao B, Zhao S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.

    Article  Google Scholar 

  2. Halfdanarson TR, Strosberg JR, Tang L, Bellizzi AM, Bergsland EK, O’Dorisio TM, et al. The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(7):863–81.

    Article  Google Scholar 

  3. Kunz PL, Graham N, Catalano PJ, Nimeiri H, Fisher GA, Longacre TA, et al. A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211). J Clin Oncol. 2022;40(16_suppl):4004.

    Article  Google Scholar 

  4. Barrett JR, Rendell V, Pokrzywa C, Lopez-Aguiar AG, Cannon J, Poultsides GA, et al. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. J Surg Oncol. 2020;121(7):1067–73.

    Article  CAS  Google Scholar 

  5. Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Parteilli S, et al. A novel validated recurrence risk score to guide a pragmatic surveillance strategy after resection of pancreatic neuroendocrine tumors: an internation study of 1006 patients. Ann Surg. 2019;270(3):422–33.

    Article  Google Scholar 

  6. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, et al. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. HPB (Oxford). 2020;22(2):215–23.

    Article  Google Scholar 

  7. Welch DR, Hurst DR. Defining the hallmarks of metastasis. Cancer Res. 2019;79(12):3011–27.

    Article  CAS  Google Scholar 

  8. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.

    Article  Google Scholar 

  9. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Program, National Institutes of Health, National Cancer Institute, Bethesda, USA

    Carrie E. Ryan MD, MS, Areeba Saif MD & Jonathan M. Hernandez MD

  2. Surgical Oncology, Oregon Health and Science University, Portland, USA

    Flavio Rocha MD

  3. Wayne State University, Detroit, USA

    Philip Philip MD

  4. University of Cincinnati School of Medicine, Cincinnati, USA

    Syed Ahmad MD & Heloisa Soares MD

Authors
  1. Carrie E. Ryan MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Areeba Saif MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Flavio Rocha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philip Philip MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Syed Ahmad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heloisa Soares MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan M. Hernandez MD.

Ethics declarations

Disclosure

Heloisa Soares—NIH/NCI/NCTN Grants U10CA180888, U10CA180819, U10CA180821, U10CA180868.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 108 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ryan, C.E., Saif, A., Rocha, F. et al. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 30, 1302–1304 (2023). https://doi.org/10.1245/s10434-022-12906-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12906-1

Search

Navigation